Literature DB >> 2994064

Recycling of epidermal growth factor in a human pancreatic carcinoma cell line.

M Korc, B E Magun.   

Abstract

PANC-1 human pancreatic carcinoma cells readily bound and internalized 125I-labeled epidermal growth factor (EGF). Bound 125I-labeled EGF was then partially processed to a number of high molecular weight acidic species. Percoll gradient centrifugation of cell homogenates indicated that the majority of 125I activity localized to several intracellular vesicular compartments. Both intact EGF and its processed species were subsequently released into the incubation medium. A major portion of the released radioactivity was capable of rebinding to the cell. Only a small amount of bound 125I-labeled EGF was degraded to low molecular weight products, and this degradation was completely blocked by methylamine. This lysosomotropic compound did not arrest either the generation or the extrusion of the major high molecular weight species of processed EGF (pI 4.2). These findings suggest that in PANC-1 cells, bound EGF undergoes only limited processing. Both intact EGF and its major processed species bypass the cellular degradative pathways, are slowly released from the cell, and then rebind to the cell.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994064      PMCID: PMC391014          DOI: 10.1073/pnas.82.18.6172

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

Review 1.  Epidermal growth factor.

Authors:  G Carpenter; S Cohen
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

2.  Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization.

Authors:  C R Savage; S Cohen
Journal:  J Biol Chem       Date:  1972-12-10       Impact factor: 5.157

3.  Journey to the center of the cell: role of the receptosome.

Authors:  I H Pastan; M C Willingham
Journal:  Science       Date:  1981-10-30       Impact factor: 47.728

4.  Vasopressin inhibition of epidermal growth factor binding to cultured mouse cells.

Authors:  E Rozengurt; K D Brown; P Pettican
Journal:  J Biol Chem       Date:  1981-01-25       Impact factor: 5.157

5.  Modulation of the epidermal growth factor receptor by platelet-derived growth factor and choleragen: effects on mitogenesis.

Authors:  W Wharton; E Leof; W J Pledger; E J O'Keefe
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

6.  Dansylcadaverine inhibits internalization of 125I-epidermal growth factor in BALB 3T3 cells.

Authors:  H T Haigler; F R Maxfield; M C Willingham; I Pastan
Journal:  J Biol Chem       Date:  1980-02-25       Impact factor: 5.157

7.  Further purification of epidermal growth factor by high-performance liquid chromatography.

Authors:  L M Matrisian; B R Larsen; J S Finch; B E Magun
Journal:  Anal Biochem       Date:  1982-09-15       Impact factor: 3.365

8.  Binding and processing of epidermal growth factor in Panc-I human pancreatic carcinoma cells.

Authors:  M Korc; B E Magun
Journal:  Life Sci       Date:  1985-05-13       Impact factor: 5.037

9.  Plasma concentrations of immunoreactive human epidermal growth factor (urogastrone) in man.

Authors:  Y Hirata; G W Moore; C Bertagna; D N Orth
Journal:  J Clin Endocrinol Metab       Date:  1980-03       Impact factor: 5.958

10.  Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts.

Authors:  F R Maxfield
Journal:  J Cell Biol       Date:  1982-11       Impact factor: 10.539

View more
  12 in total

Review 1.  Treatment of pancreatic cancer. Promises and problems of tamoxifen, somatostatin analogs, and gemcitabine.

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1997-10

2.  Ligand-mediated internalization, recycling, and downregulation of the epidermal growth factor receptor in vivo.

Authors:  W H Lai; P H Cameron; I Wada; J J Doherty; D G Kay; B I Posner; J J Bergeron
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

Review 3.  Pancreatic cancer: a review of emerging therapies.

Authors:  L Rosenberg
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

4.  Transforming growth factor alpha (TGF-alpha) increases cell number in a human pancreatic cancer cell line but not in normal mouse pancreas.

Authors:  B Kullenberg; C Jansen; N Fredäng; B Ohlsson; J Axelson
Journal:  Int J Pancreatol       Date:  2000-12

5.  Augmentation of chemically induced pancreatic and bronchial cancers by epidermal growth factor.

Authors:  R A Malt; J F Chester; H A Gaissert; J S Ross
Journal:  Gut       Date:  1987       Impact factor: 23.059

Review 6.  Potential role of the epidermal growth factor receptor in human pancreatic cancer.

Authors:  M Korc
Journal:  Int J Pancreatol       Date:  1990 Aug-Nov

7.  Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells.

Authors:  Mariano Hurtado; Juan José Lozano; Elisabeth Castellanos; Luis A López-Fernández; Keith Harshman; Carlos Martínez-A; Angel R Ortiz; Timothy M Thomson; Rosanna Paciucci
Journal:  Gut       Date:  2007-04-23       Impact factor: 23.059

Review 8.  Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors.

Authors:  H Friess; P Berberat; M Schilling; J Kunz; M Korc; M W Büchler
Journal:  J Mol Med (Berl)       Date:  1996-01       Impact factor: 4.599

Review 9.  Biology of pancreatic cancer.

Authors:  G J Poston; J Gillespie; P J Guillou
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

10.  Growth factors and pancreatic cancer.

Authors:  M Korc
Journal:  Int J Pancreatol       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.